Identification of the Epigenetic Response to Trauma
TrauMeth
1 other identifier
observational
365
1 country
1
Brief Summary
The objective of this study is to investigate potential early alterations in the DNA methylation profile after severe trauma and to investigate if the early marks persist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2019
CompletedStudy Start
First participant enrolled
June 3, 2019
CompletedFirst Posted
Study publicly available on registry
June 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedNovember 9, 2021
November 1, 2021
1.9 years
May 29, 2019
November 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Immediate DNA methylation profile
Immediate (\< 4 hours) post-trauma DNA methylation profile in blood cells compared to the pre-surgery (baseline) and immediate post-surgery (\< 4 hours) DNA methylation profile in blood cells.
Day of trauma/surgery
Secondary Outcomes (7)
Pre-trauma/-surgery DNA methylation profile
Pre-trauma/surgery
Stability of DNA methylation profile
30-45 days after trauma/surgery
Change in DNA methylation profile; pre-trauma/-surgery to post-trauma/-surgery
Day of trauma/surgery
Change in DNA methylation profile; immediately post-trauma/-surgery to one month post-trauma/-surgery
0 to 30-45 days after trauma/surgery
DNA methylation changes in relation to injury severity
Day 0-45 after trauma/surgery
- +2 more secondary outcomes
Study Arms (2)
Trauma patients
All trauma patients admitted to Rigshospitalet's trauma center will have a blood sample taken during the initial treatment and 30 days after the trauma.
Patients admitted for elective orthopedic surgery
The patients will have a blood sample taken before and after surgery and again 30 days after the surgery.
Interventions
DNA from blood samples will be isolated and analyzed for genome-wide DNA methylation patterns using the Infinium HumanMethylationEPIC BeadChip (Illumina, San Diego, CA, USA).
Eligibility Criteria
The study population consists of all trauma patients admitted to RH's trauma center generating a trauma team activation. The control group will consist of patients admitted to RH's orthopedic department for elective surgery.
You may qualify if:
- Age 18-65 years.
- Trauma patients: Admitted to Rigshospitalet's trauma center generating a trauma team activation.
- Surgical controls: Admitted for elective surgery (non-traumatic cause) at the orthopedics department AND
- Only one surgical procedure planned from study day 0 to study day 45.
- Expected procedure length of at least 60 minutes.
You may not qualify if:
- Not able to obtain informed consent and not possible to obtain consent from a next-of-kin.
- Trauma patients:
- Secondary transfers.
- Pre-hospital blood transfusion OR blood transfusion in the trauma center before the first blood sample is obtained.
- First blood sample taken later than 4 hours after the trauma.
- Patients in cardiac arrest before/after hospital admission.
- Surgical controls:
- Surgical procedures due to cancer or fractures.
- First post-operative blood sample taken later than 4 hours after surgical end time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, 2100, Denmark
Biospecimen
Blood samples are obtained from patients to investigate DNA methylation profiles
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jacob Steinmetz, MD, Ph.D.
Rigshospitalet, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
May 29, 2019
First Posted
June 4, 2019
Study Start
June 3, 2019
Primary Completion
April 15, 2021
Study Completion
August 1, 2021
Last Updated
November 9, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share